Redeye: Sdiptech - Allocating capital to the right places


22 juli, 08:19

Redeye updates its estimates and valuation following Sdiptech’s Q2 2025 report, which was broadly in line with consensus but ahead of our expectations, driven by a stronger-than-anticipated gross margin. While sales came in slightly below forecast due to postponed orders, these are expected to materialise in Q3. The company also accelerated its strategic review, initiating the process of divesting subsidiaries representing c15% of sales and 5% of EBITA, with a goodwill write-down of SEK400-500m expected in Q3. We view this as a logical step in the refinement of the acquisition strategy initiated back in 2018-2019. Following the report and a change of lead analyst, we have adjusted our estimates and valuation, lowering our fair value range while maintaining a healthy upside in our Base Case.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Sdiptech - Allocating capital to the right places

Läs mer på MFN



Marknadsöversikt

1 DAG %

Senast

1 mån
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.